Bioxytran Inc (BIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,776 | -2,543 | -1,671 | -1,469 | -541 |
| Depreciation Amortization | N/A | 259 | 259 | 243 | 167 |
| Other Working Capital | 611 | 263 | 363 | 198 | 62 |
| Other Operating Activity | 775 | 922 | 841 | 832 | 156 |
| Operating Cash Flow | $-391 | $-1,099 | $-208 | $-196 | $-157 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | -9 | -10 | N/A | N/A | N/A |
| Other Investing Activity | -9 | -10 | 0 | 0 | 0 |
| Investing Cash Flow | $-9 | $-10 | $0 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | 264 | 264 | 264 | 264 |
| Debt Issued | N/A | N/A | 8 | N/A | N/A |
| Common Stock Issued | 450 | 950 | 0 | 0 | 0 |
| Other Financing Activity | 0 | -233 | -233 | -233 | -233 |
| Financing Cash Flow | $450 | $981 | $39 | $31 | $31 |
| Beginning Cash Position | 42 | 170 | 170 | 170 | 170 |
| End Cash Position | 92 | 42 | 1 | 4 | 44 |
| Net Cash Flow | $50 | $-128 | $-169 | $-165 | $-126 |
| Free Cash Flow | |||||
| Operating Cash Flow | -391 | -1,099 | -208 | -196 | -157 |
| Free Cash Flow | -391 | -1,099 | -208 | -196 | -157 |